Susceptibilities of Propionibacterium acnes ophthalmic isolates to moxifloxacin

Propionibacterium acnes has become an important pathogen in nosocomial infection, including endophthalmitis. The treatment of endophthalmitis presents many diagnostic and therapeutic challenges. Although P. acnes has demonstrated in vitro susceptibilities to many beta-lactam agents, clindamycin, and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Antimicrobial agents and chemotherapy 2001-10, Vol.45 (10), p.2969-2970
Hauptverfasser:	Dali, P, Giugliano, E R, Vellozzi, E M, Smith, M A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Infective Agents - pharmacology Aza Compounds Fluoroquinolones Humans Letters to the Editor Microbial Sensitivity Tests Moxifloxacin Propionibacterium acnes Propionibacterium acnes - drug effects Propionibacterium acnes - isolation & purification Quinolines
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Propionibacterium acnes has become an important pathogen in nosocomial infection, including endophthalmitis. The treatment of endophthalmitis presents many diagnostic and therapeutic challenges. Although P. acnes has demonstrated in vitro susceptibilities to many beta-lactam agents, clindamycin, and macrolides, intravitreal treatment success in patients has been inconsistent.
ISSN:	0066-4804 1098-6596
DOI:	10.1128/AAC.45.10.2969-2970.2001